Carwin Pharmaceutical Associates, LLC received FDA clearance for its potassium chloride oral formulation POKONZA, a move expected to expand generic supply and increase market competition in the potassium supplementation sector.
Carwin Pharmaceutical Associates, LLC received FDA clearance for its potassium chloride oral formulation POKONZA, a move expected to expand generic supply and increase market competition in the potassium supplementation sector.